Clincosm LogoSign in Get a demo

melanoma (skin)

Showing 1 - 25 of 328
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma (Skin) Trial in Omsk, Saint Petersburg (BCD-201, Keytruda)

Recruiting
  • Melanoma (Skin)
  • Omsk, Russian Federation
  • +2 more
Aug 1, 2023

Melanoma (Skin) Trial in Stockholm (LifeChamps Platform)

Active, not recruiting
  • Melanoma (Skin)
  • LifeChamps Platform
  • Stockholm, Sweden
    Academic Primary Health Care Centre
Aug 6, 2023

Avoidance of Futile Excisions Through Skin Tele-triage

Enrolling by invitation
  • Melanoma (Skin)
  • Telemedicine
  • Single Assessor Teledermatological triage (TDT)
  • +3 more
  • Brønshøj, Copenhagen, Denmark
    Gustav Gede Nervil
Aug 1, 2023

Liquid Biopsy, Melanoma (Skin), Melanoma Stage III Trial in Rome (Affinity Mediated Transport Amplification (AMT))

Recruiting
  • Liquid Biopsy
  • +4 more
  • Affinity Mediated Transport Amplification (AMT)
  • Rome, Italy
    "Regina Elena" National Cancer Institute
Jul 13, 2023

Melanoma (Skin), Liquid Biopsy Trial in Roma (Biopsy)

Recruiting
  • Melanoma (Skin)
  • Liquid Biopsy
  • Biopsy
  • Roma, Italy
    IRE
Jun 7, 2023

EVALUATING THE CURRENT STANDARD OF CARE FOR PATIENTS DIAGNOSED

Not yet recruiting
  • Melanoma (Skin)
  • Melanoma
    • (no location specified)
    Jun 2, 2023

    Melanoma (Skin) Trial (Sodium Chloride Granules, Water)

    Not yet recruiting
    • Melanoma (Skin)
    • Sodium Chloride Granules
    • Water
    • (no location specified)
    May 2, 2023

    NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +32 more
    • (no location specified)
    Mar 30, 2023

    Resectable Melanoma, Melanoma Stage III, Melanoma (Skin) Trial in Belarus, Russian Federation (BCD-217, anti-PD1, Excision of

    Recruiting
    • Resectable Melanoma
    • +2 more
    • BCD-217
    • +3 more
    • Lesnoy, Belarus
    • +35 more
    Feb 21, 2023

    Melanoma, Melanoma (Skin), Melanoma Stage III Trial in Belarus, India, Russian Federation (BCD-217, BCD-100, Placebo)

    Recruiting
    • Melanoma
    • +6 more
    • BCD-217
    • +2 more
    • Babruysk, Belarus
    • +62 more
    Feb 8, 2023

    Consensus Agreement Diagnosis Made by Dermatopathology Experts

    Enrolling by invitation
    • Melanoma (Skin)
    • Pigmented Lesions
      • Herlev, Denmark
        Herlev University Hospital
      Feb 7, 2023

      Melanoma (Skin) Trial in Houston (BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab)

      Not yet recruiting
      • Melanoma (Skin)
      • BMS-986213 (Relatlimab-Nivolumab FDC)
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 1, 2023

      Melanoma (Skin), Cutaneous Melanoma, Adult Disease Trial in France, Spain, United States (ANV419, Pembrolizumab, Ipilimumab)

      Recruiting
      • Melanoma (Skin)
      • +4 more
      • Bloomington, Minnesota
      • +7 more
      Jan 31, 2023

      Breast Cancer, Prostate Cancer, Melanoma (Skin) Trial in Baltimore (Written Weight Loss Material, Weight Loss App, Behavioral

      Active, not recruiting
      • Breast Cancer
      • +7 more
      • Written Weight Loss Material
      • +2 more
      • Baltimore, Maryland
        Johns Hopkins ProHealth
      Jan 19, 2023

      Melanoma (Skin) Trial in Tampa (biological, drug, procedure)

      Active, not recruiting
      • Melanoma (Skin)
      • NY-ESO-1 157-165 (165V)
      • +5 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Jan 17, 2023

      Melanoma (Skin) Trial in Tampa (MART-1, NY-ESO-1, gp100:209-217(210M))

      Completed
      • Melanoma (Skin)
      • MART-1
      • +5 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Jan 17, 2023

      Sentinel Lymph Node, Melanoma (Skin), Breast Cancer Trial in Atlanta, Poughkeepsie, Hershey (IC-Green KIT)

      Completed
      Has Results
      • Sentinel Lymph Node
      • +2 more
      • IC-Green KIT
      • Atlanta, Georgia
      • +2 more
      Dec 19, 2022

      Melanoma (Skin), Skin Cancer, Skin Melanoma Trial in Tampa (Vemurafenib, Cobimetinib)

      Recruiting
      • Melanoma (Skin)
      • +3 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Dec 30, 2022

      Melanoma (Skin), Carcinoma Trial in Copenhagen (Dermloop Learn)

      Completed
      • Melanoma (Skin)
      • Carcinoma
      • Dermloop Learn
      • Copenhagen, Danmark, Denmark
        AISC Research Fascility
      Dec 13, 2022

      Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV Trial in Iowa City, Rochester, Madison ([212Pb]VMT01)

      Not yet recruiting
      • Melanoma (Skin)
      • +5 more
      • Iowa City, Iowa
      • +2 more
      Dec 8, 2022

      Melanoma (Skin) Trial in Nice, Montpellier, Lille (Evaluation of cytokine production)

      Not yet recruiting
      • Melanoma (Skin)
      • Evaluation of cytokine production
      • Nice, Alpes-maritimes, France
      • +2 more
      Dec 5, 2022

      Malignant Melanoma, Melanoma (Skin), Melanoma Stage III Trial in United Kingdom (SCIB1 DNA vaccine)

      Recruiting
      • Malignant Melanoma
      • +3 more
      • SCIB1 DNA vaccine
      • Cardiff, United Kingdom
      • +6 more
      Dec 7, 2022

      Will Permit Sites to Proactively Assess TAA, HLA and HPV-16

      Terminated
      • Head and Neck Cancer
      • +7 more
      • Tumor Profiling
      • Scottsdale, Arizona
      • +2 more
      Dec 2, 2022

      Suspected Melanoma Utilizing DermTech's Non-invasive Adhesive

      Completed
      • Melanoma (Skin)
      • +2 more
        • Chevy Chase, Maryland
        • +1 more
        Oct 27, 2022

        Melanoma (Skin) Trial in Enschede, Hengelo (Magnetic sentinel lymph node biopsy by use of Magtrace®, in combination with

        Not yet recruiting
        • Melanoma (Skin)
        • Magnetic sentinel lymph node biopsy by use of Magtrace®, in combination with SentiMag® and DiffMag
        • Enschede, Netherlands
        • +1 more
        Oct 3, 2022